[ Price : $8.95]
FDA commissioner Marty Makary says the agency is planning to release in the coming days a vaccine development framework to help wi...[ Price : $8.95]
FDA approves Amneals Brekiya, the only dihydrogotamine mesylate autoinjector available to treat migraine and cluster headaches in ...[ Price : $8.95]
FDA accepts a BioCryst NDA for Orladeyo to be used in pediatric patients with hereditary angioedema.[ Price : $8.95]
Merck's Keytruda meets a Phase 3 clinical trial primary endpoint of progression-free survival for treating patients with platinum-...[ Price : $8.95]
FDA approves an Incyte supplemental BLA for Zynyz (retifanlimab-dlwr) in combination with carboplatin and paclitaxel for the first...[ Price : $8.95]
FDA warns Chinas Shantou S.E.Z. Baojie Industry about CGMP violations in its production of finished drugs, some of which may be re...[ Price : $8.95]
Biotech executives, investors, and consultants say some companies are moving early clinical trials overseas due to fears of instab...[ Price : $8.95]
FDA approves a Merck NDA for Welireg (belzutifan), an oral drug for treating adults and pediatric patients aged 12 and older with ...